Encouraging cervical cancer screening in under-screened women aged 50 to 74
Tests letters and home HPV self-sampling kits in women 50 to 74.
Plain-language title generated from the registry record
Registry title: Breast Cancer-Related Approach for Increasing Cervical Cancer Screening
Key facts
- Where
- Geneva, SwitzerlandSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 74 years old?
Source: NCT07171658, who can take part
Where in Switzerland
- University Hospitals of GenevaGeneva, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Jessica Di Vincenzo Sormani
- Trial code
- NCT07171658
- Record updated
- 22 December 2025
- Original description
The primary objective of this clinical trial is to assess cervical cancer screening participation among under-screened women invited through organized breast cancer screening programs in Switzerland.Read full original descriptionShow less
Improving Cervical Cancer Screening Coverage Among Underscreened Women Aged 50 to 74 in Switzerland Using HPV Self-sampling Strategies: A Randomized Study - Breast Cancer-Related Approach for Increasing Cervical Cancer Screening
The primary objective of this clinical trial is to assess cervical cancer screening participation among under-screened women invited through organized breast cancer screening programs in Switzerland.
This randomized trial will compare three arms:
1. Intervention group 1: Sensitization to Cervical Cancer (CC) screening Women will receive an awareness letter explaining the importance of cervical cancer screening, the Swiss recommendations and an invitation to schedule an appointment. 2. Intervention group 2: Home-based Human papillomavirus infection (HPV) self-sampling Women will receive a free-of-charge vaginal self-sampling kit for HPV infection 3. Observational control group Women selected in the control arm will only be recruited one year following the screening of those in the intervention arm (T0+1), as to not influence Cervical Cancer Screening (CCS) behavior during this period by being reminded of screening recommendations.
Inclusion: Women receiving Breast Cancer Screening (BCS) invitation letters in the selected five cantons (Geneva, Bern (francophone), Jura, Neuchâtel, and Vaud); Aged 50 to 74 years old; Not been screened for cervical cancer in the past three years; Speaking one of the 6 languages of the study (French, German, Italian, and in English, Spanish, and Portuguese).
Exclusion: Prior cervical cancer diagnosis,; Hysterectomy; Non consent to participate to the study; Incapable of judgment or under tutelage; Pregnancy.